Please check your internet connection and try again.
## Iv Dexamethasone
### Overview
Dexamethasone is a potent synthetic corticosteroid with potent anti-inflammatory and immunosuppressive effects. It is available for intravenous administration.
### Primary Indications
* Management of severe allergic reactions
* Adjunct in the treatment of cerebral edema
* Management of certain dermatological conditions
* Adjunct in the treatment of septic shock (controversial and typically used in specific contexts)
* Management of nausea and vomiting associated with chemotherapy
* Management of adrenal insufficiency (as replacement therapy)
### Adult Dosing
Dosing is highly variable and depends on the specific indication and severity of the condition. Common doses range from **4 mg to 24 mg intravenously every 6, 12, or 24 hours**. Higher doses may be used for specific indications like cerebral edema or septic shock. Specific protocols (e.g., for COVID-19) dictate precise dosing regimens.
### Pediatric Dosing
Dosing is weight-based and indication-specific. Common pediatric doses range from **0.15 mg/kg to 0.4 mg/kg intravenously every 12 or 24 hours**. Maximum doses typically align with adult maximums or are specified by local protocols.
### Dose Adjustments
* **Hepatic Impairment:** No specific dose adjustment is universally recommended, but impaired liver function may reduce corticosteroid metabolism, potentially increasing effects and toxicity. Close monitoring is advised.
* **Renal Impairment:** No dose adjustment is typically required.
### Contraindications
* Systemic fungal infections
* Hypersensitivity to dexamethasone or other components of the formulation
### Adverse Effects
* **Common:** Hyperglycemia, insomnia, increased appetite, mood changes (euphoria, irritability, psychosis), fluid retention, hypertension, increased risk of infection.
* **Serious:** Adrenal suppression, Cushingoid appearance, peptic ulceration, osteoporosis, aseptic necrosis of bone, growth suppression (in children), exacerbation of infections, glaucoma, cataracts.
### Key Drug Interactions
* **CYP3A4 Inducers (e.g., rifampin, phenytoin, carbamazepine):** May decrease dexamethasone efficacy.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase dexamethasone levels.
* **Diuretics (non-potassium-sparing):** Increased risk of hypokalemia.
* **Antidiabetics:** May require dose adjustment due to hyperglycemia.
* **Live Vaccines:** Increased risk of disseminated infection. Avoid concurrent use.
### Monitoring
* Blood glucose levels (especially in diabetic patients or those receiving high doses)
* Electrolytes (potassium)
* Signs and symptoms of infection
* Fluid status (edema, weight gain)
* Psychiatric status
* Ophthalmologic examination (long-term use)
* Bone density (long-term use)
* Growth (in pediatric patients)
* Adrenal function (particularly upon withdrawal)
### Clinical Pearls
* Dexamethasone is a long-acting corticosteroid.
* Tapering the dose is crucial when discontinuing long-term therapy to prevent adrenal insufficiency.
* Consider concurrent administration of gastroprotective agents (e.g., PPIs) in patients at risk for peptic ulcer disease.
* Be aware of the potential for masking signs of infection.
* Use with caution in patients with existing infections, hypertension, heart failure, osteoporosis, and psychiatric disorders.
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for comprehensive drug information resources. Always consult the official prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing and indications can vary based on patient-specific factors and local institutional protocols.
